ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1214

The Impact of Periodontal Disease On Early Inflammatory Arthritis Persists Even After All Teeth Are Lost

Gisela Westhoff1, Paola de Pablo2, Thomas Dietrich3, Georg Schett4 and Angela Zink5, 1Epidemiology Unit, German Rheumatism Research Center Berlin, Berlin, Germany, 2Rheumatology, College of Medical & Dental Sciences, IBR 3rd floor, University of Birmingham, Birmingham, United Kingdom, 3College of Medical and Dental Sciences, The School of Dentistry, University of Birmingham, Birmingham, UK, Birmingham, United Kingdom, 4Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Prognostic factors and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Data suggests that individuals with periodontal disease (PD) may be more likely to develop rheumatoid arthritis (RA) and have worse disease activity. PD is a common inflammatory disease characterized by gingival accumulation of inflammatory cells with endothelial cell proliferation and matrix degradation that may worsen joint inflammation. Since PD is a major cause of tooth loss, tooth loss may be a surrogate marker for chronic PD, an inflammatory process that may possibly end when the last tooth is lost. We therefore hypothesized that partial vs. complete tooth loss (edentulism) may be differentially associated with disease activity in persons with early arthritis naive to DMARD-therapy.

Methods: The study sample included 1,009 patients with early arthritis (<6 months) naive to DMARD-treatment, enrolled in an ongoing longitudinal study (CAPEA 2010-2013). Data collection included disease activity (DAS28 calculated by TJC28, SJC28, ESR and Patient Global (PG; NRS 0-10)), the 2010 ACR-EULAR RA classification criteria and self-reported number of teeth. Patients were categorized according to number of teeth at study entry (no teeth, 1-19, 21-27, all teeth). Analysis of covariance was done to determine baseline disease activity by number of teeth.

Results: Study participants (65% female) were 55 ±14 years old and had mean symptom duration of 12 ±7 weeks. 56% were RF and/or ACPA positive and 66% fulfilled the 2010 criteria for RA. No patient had received any DMARDs at baseline. Sample characteristics by tooth loss categories are shown on Table 1. Significantly more participants with edentulism met ACR/EULAR classification compared with those with complete dentition (OR 1.9, 95% CI 1.01-3.35; adjusted for age, sex, BMI, smoking, and DAS28). Edentulous patients had neither lower nor higher disease activity (DAS28) than patients with considerable tooth loss (1-19 teeth left). However, compared with those with moderate tooth loss (20-27; P = 0.046) or complete dentition (P = 0.006), they had significantly worse disease activity.

 

Number of teeth

N

%

Age*

 § RF/ACPA pos. %

# RA %

& ESR *

 ~ CRP
mg/l*

TJC28*

PG*

DAS28 ESR*#
(95% CI)

edentulous

77

7.6

68.2

65

75

45

28

10.0

5.5

5.2 (4.8-5.5)

1-19

289

28.6

63.7

54

70

39

27

10.0

5.3

5.3 (5.1-5.4)

20-27

401

39.7

53.6

55

65

28

18

7.8

4.9

4.8 (4.7-4.9)

all teeth

242

24.0

43.9

56

60

24

13

7.7

4.8

4.6(4.4-4.8)

Total

1.009

100.0

55.3

56

66

32

22

8.6

5.0

4.9

P = no vs.
1-19 teeth

 

 

0.001

0.055

0.270

0.080

0.828

0.955

0.578

0.470

P = no vs.
all teeth

 

 

<0.001

0.101

0.011

<0.001

0.017

0.013

0.055

0.006

§ rheumatoid factor and/or anti citrullinated peptide antibody; # ACR-EULAR RA classification criteria points (0-10; ≥6 =RA); ; & erythrocyte sedimentation rate; ~ C-reactive protein; *means, adjusted to 55.0 years of age

Conclusion: Tooth loss was associated with disease activity at disease onset in a large cohort of patients with early inflammatory arthritis (IA) naïve to DMARD-therapy. Contrary to the assumption that exposure to periodontal disease ends once all affected teeth are lost, edentulism does not improve the interrelation of dental health and IA. The impact of PD on IA starts before IA onset, and obviously persists even after all teeth have been lost. The data also support the notion that there might be a common underlying pathobiology for both conditions.


Disclosure:

G. Westhoff,
None;

P. de Pablo,
None;

T. Dietrich,
None;

G. Schett,
None;

A. Zink,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-periodontal-disease-on-early-inflammatory-arthritis-persists-even-after-all-teeth-are-lost/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology